1.The pediatric epilepsy surgery in China
Neurology Asia 2007;12(Supplement 1):33-35
There is rapid growth of pediatric surgery service in China in the recent years. A survey by the China
Association �A gainst �Epi�lepsy underta�ken in �June ����� 2006���� on the ma�jor cities in different parts of the
country showed a dramatic increase particularly in years 2004 and 2006. Surgery for temporal lobe
epilepsy accounts for half of the operation. Surgery has an important role in the treatment of drug
resistant pediatric epilepsy. With large population and vast geographical spread, it is important to
further develop pediatric epilepsy surgery service in China
2.Epilepsy surgery in China: The history and current development
Neurology Asia 2007;12(Supplement 2):1-3
The earliest activities related to epilepsy surgery in China ma�� � y be tra�ce��d to the 19���50s an�� �� d 60s��. A�ter
a lull during the cultural revolution, there was resurgence of epilepsy surgery from the 1980s, and
rapid development from 2000. It is estimated that app�roximately 150- ���200 p hysi�cians �currentl�� � y pra�cti�ce
epilepsy surgery in the country.�� In year 2��� 005, there were a total of 2,��500 �cases of e�pile�ps��y o�perate��d in
whole of �China, close to half in Beijing, Tian�jin, �Shanghai, �Chongqing an��d Guang�zhou, an�� a �uarter
in Beijing. There are three Chinese epilepsy surgery journals, 5 monographs on epilepsy surgery, and
“��Epilepsy surgery” edite�� ��� ��� �� ��� ��� d by HO Luders has also �been translate��d into �Chinese��.
3.Temporoparietooccipital and parietooccipital disconnection in patients with intractable epilepsy
Yuguang Guan ; Guoming Luan ; Jian Zhou
Neurology Asia 2013;18(s1):57-59
Objective: To assess the surgical techniques and surgical outcomes of temporoparietooccipital and
parietooccipital disconnection. Methods: The authors conducted a retrospective review of clinical,
neuropsychological, EEG, imaging data in 16 patients with intractable epilepsy who underwent
temporoparietooccipital and parietooccipital disconnection between April 2008 and October 2011.
Of the 16 cases, 12 were males and 4 were females. The age of seizure onset was from 0.1 to 27
years (average 6.6) and disease duration of 0.1 to 18 years (average 7.5). The surgery was performed
between the age of 3 and 37 years (average 14.1). Nine patients underwent temporoparietooccipital
disconnection, 5 patients parietooccipital disconnection and 2 patient parietooccipital disconnection
and temporal lobotomy. Results: After a mean follow-up of 1.6 years (range 0.5–3.9 years), 13 patients
(81%) were seizure free, 1 patient had Engel Class II seizure outcome and 2 patient had Engel class
III outcome. Two patients exhibited severe brain swelling and one patients had second resective
operation with good recovery. None of the patients developed new motor defi cits postoperatively and
there was no mortality.
Conclusion: Temporoparietooccipital and parietooccipital is a safety and effective epilepsy surgery
procedure for patients with epileptic zone localization to the posterior quadrant on one side. The results
of surgical disconnection for posterior quadrantic epilepsy have yielded excellent seizure outcomes
in 81% of the patients, with no mortality or major morbidity.
4.IMMUNOGOLD LOCALIZATION OF GFAP AND MDR1 IN SURGICALLY RESECTED BRAIN TISSUES FROM CLINICAL INTRACTABLE EPILEPSY PATIENTS BY TRANSMISSION ELECTRON MICROSCOPY
Chengyun DING ; Qunyuan XU ; Guoming LUAN
Acta Anatomica Sinica 2002;0(06):-
Objective To determine the ultrastructural localization of MDR1 and GFAP in the surgically resected brain tissues from intractable epilepsy patients. Methods Expression of MDR1 and GFAP in brain tissues was examined by using PAG immunolabeling technique for electron microscopy. Results The MDR1 and GFAP labeled by gold particles were only detected at some reactive astrocytes. The positive gold particles were mainly located in the astrocytic cytoplasm and their membrane, but not in the nucleus.Conclusion The expression of MDR1 and GFAP in the brain of patients with clinically intractable epilepsy were mainly located at the cytoplasm and membrane of certain reactive astrocytics.;
5.Findings of Transcranial Doppler during Simple Partial Seizures with Rasmussen Encephalitis: 8 Cases Report
Xiaowei WU ; Xingzhou LIU ; Guang HUANG ; Guoming LUAN ; Shuhua CHEN ; Wei ZHANG
Chinese Journal of Rehabilitation Theory and Practice 2010;16(7):664-665
Objective To analyze the blood flow velocities in middle cerebral artery with Rasmussen encephalitis. Methods8 patients with Rasmussen encephalitis were detected bilateral middle cerebral artery in both period of onset and intermission during simple partial seizures with Transcranial Doppler. ResultsThe mean velocity variance between focus side and non-focus side was minimums among the 3 indexes observed. The mean velocity of MCA displayed uneven increase during seizures. ConclusionThe mean velocity was the most stable index for judging.
6.Changes of Blood Flow Velocities in Middle Cerebral Artery with Rasmussen Encephalitis: 8 Cases Report
Xiaomo WU ; Xingzhou LIU ; Guang HUANG ; Guoming LUAN ; Shuhua CHEN ; Wei ZHANG
Chinese Journal of Rehabilitation Theory and Practice 2010;16(5):465-467
ObjectiveTo discuss clinical significance of changes in cerebral blood flow velocities with Rasmussen encephalitis. Methods8 cases diagnosed as Rasmussen encephalitis were measured the blood flow velocities in middle cerebral artery (MCA) with transcranial Doppler in ictal and interictal seizures. ResultsIctal mean flow velocity in the ipsilateral MCA to the epileptogenic foci increased 14.02%~48.14% to interictal one, while it was -0.74%~22.63% in the contralateral MCA. ConclusionAn increased flow velocity has been found in the ipsilateral MCA to the epileptogenic foci during seizure in Rasmussen encephalitis patients.
7.The expression of Tau protein in the brains of the intractable epilepsy patients
Jianhua WANG ; Xuefeng WANG ; Yun GONG ; Yong YAN ; Guoming LUAN ; Yuping WANG ; Yunlin LI ; Jianguo ZHANG ; Yong LU ; Hongwei LI
Chinese Journal of Neurology 2005;0(09):-
Objective To explore the expression of Tau protein in brains of the intractable epilepsy patients and discuss its function in the pathogenesis. Methods Immunohistochemistry was adapted to test the expression of Tau protein and the mossy fiber sprouting in the hippocampus and cortex of temporal lobe from 48 intractable epilepsy patients and age-mached 48 cases of controls. Results The expression of phosphorylated Tau protein in the CA_3 areas (0.0450?0.0115) and the molecular layers of dentate gyrus (0.0463?0.0120) in intractable epilepsy patients was increased, accompanied by the hippocampus mossy fiber sprouting (3.18?0.35). No difference on the expression of total Tau protein was observed between the intractable epilepsy patients and the controls. Conclusion The present findings demonstrate that the strengthening of phosphorylated Tau protein might play an important role for the synaptic reorganization of the hippocampus. Thus, the changes of phosphorylated Tau protein could improve clinical prognosis in the intractable epilepsy patients.
8.Treatment of symptomatic epilepsy with lesionectomies combined with bipolar coagulation of the surrounding cortex.
Chinese Medical Journal 2003;116(12):1930-1932
OBJECTIVETo observe the clinical effects of lesionectomies combined with bipolar coagulation of the surrounding cortex (BCSC) on symptomatic epilepsy.
METHODSThe effectiveness of lesionectomies combined with BCSC (71 patients) and of lesionectomies alone (78 patients) were compared in follow-up surveys conducted 2 - 5 years (average of 37 months) post-operation.
RESULTSTreatment in the BCSC group was significantly more effective than in the lesionectomy group (P < 0.01). Meanwhile, patients in the BCSC group suffered no permanent post-operative complications.
CONCLUSIONLesionectomy combined with BCSC is a new, effective and safe treatment for symptomatic epilepsy.
Adolescent ; Adult ; Cerebral Cortex ; surgery ; Child ; Electrocoagulation ; methods ; Epilepsy ; surgery ; Female ; Humans ; Male ; Middle Aged ; Treatment Outcome
9.The overexpression of ULBP2 in the brain of drug-refractory epilepsy
Lifeng GUAN ; Xuefeng WANG ; Tao LIN ; Yan ZENG ; Jinmei LI ; Fei XIAO ; Jijun SUN ; Xi ZHU ; Hui YANG ; Guoming LUAN ; Yuping WANG ; Yong LU ; Hongwei LI
Chinese Journal of Immunology 2000;0(11):-
Objective:To study the expression of ULBP2 protein in the brain tissues of patients with drug-refractory epilepsy and its clinical significance.Methods:Gene-chip,immunofluorescence and Western blot were used to test expression of ULBP2 in the surgically removed brain tissue of patients with drug-refractory epilepsy from the brain bank of our department(n=42),and the results were compared with that of normal controls (n=12).Results:The relative increasing expression of ULBP2-gene in the brain of patients with drug-refractory epilepsy,and ULBP2 protein expression was significantly increased in temporal lobe cortex of patients with drug-refractory epilepsy as compared with the same regions of the controls specimens.Conclusion:The results indicate that the overexpression of ULBP2 may be involved in the pathophysiology of drug-refractory epilepsy.
10. Neuropathologic findings in intractable epilepsy: a clinicopathologic analysis of 822 cases
Zejun DUAN ; Kun YAO ; Jian ZHOU ; Lin LI ; Feng ZHAI ; Changqing LIU ; Zhong MA ; Yu BIAN ; Guoming LUAN ; Xueling QI
Chinese Journal of Pathology 2017;46(10):673-678
Objective:
To investigate the clinicopathologic characteristics of intractable epilepsy.
Methods:
Based on the classification criteria proposed by the International League Against Epilepsy (ILAE), a retrospective analysis of the pathological characteristics was done in 822 patients who underwent epilepsy surgery in Sanbo Brain Hospital, Capital Medical University, from June 2008 to December 2012.
Results:
The mean age of epilepsy onset was 9.9 years, mean duration of epilepsy was 11.9 years. Complex partial seizures were the main presenting features. Histopathological study showed 33 cases (4.01%) with mild forms of cortical malformations, 690 cases (83.94%) with focal cortical dysplasia (FCD) and 99 cases with others (including 39 pure hippocampal sclerosis, 20 cystosclerosis, 19 Sturge-Weber syndrome, 8 tuberous sclerosis complex, 6 without significant pathological changes, 5 gyral malformations and 2 hamartoma). Among the 690 FCD cases, 106 were FCD typeⅠ, 91 were FCD typeⅡ and 493 were FCDⅢ(Ⅲa: 160, Ⅲb: 106, Ⅲc: 26 and Ⅲd: 201).
Conclusions
FCDⅢd is the most common histopathological subtype causing intractable epilepsy, mainly due to focal hypoxia/ischemia in the perinatal period, which results in scarring of local brain tissue; this is followed by other isolated forms of FCD (FCDⅠand FCDⅡ), and then FCD Ⅲa and FCD Ⅲb. The reason to distinguish isolated forms of FCD (types Ⅰ and Ⅱ) from FCD Ⅲ and to subclassify FCD Ⅲ is to allow better definition of cortical dyslamination. Therefore, the pathogenic factors of intractable epilepsy can be grouped in greater details, and facilitate the diagnosis and potential curative treatment of intractable epilepsy.